Gemini Horoscope: Hello, curious Gemini! Being an air sign, your adaptability, intellect, and rapid wit ensure your world is ...

Roche’s Genentech plans to start its Phase 3 this quarter, but primary completion will happen by 2028. Click here to find out ...

William Blair analysts view Elevidys’ three-year outcome as a win, though remain sceptical on the readout’s impact on sales ...

SRPT jumps nearly 8% after Elevidys shows sustained motor gains and slower progression three years post-dose in the phase III EMBARK DMD study.

Daridorexant is a dual orexin receptor antagonist being developed by Nxera for the treatment of adult patients with insomnia and is approved and marketed in Japan as QUVIVIQ®Phase 3 trial of ...

Amazon, Cisco & Meta show improving volatility-adjusted relative strength versus their benchmarks, suggesting a transition ...

Alphamab Oncology (Stock Code: 9966.HK) announced that the results from a phase III clinical study for the treatment of ...

Johnson & Johnson announced positive topline results from the Phase 2b JASMINE study of adults living with systemic lupus erythematosus and the initiation of a Phase 3 program. The JASMINE study met ...

With Enhertu and Datroway, Daiichi Sankyo has made itself a top-tier player in antibody-drug conjugates. | With Enhertu and Datroway, Daiichi Sankyo has made itself a top-tier player in antibody-drug ...

Meta stock rose after Q4 earnings beat estimates, offsetting big capex spending. The company's call with analysts will kick ...

When a biotech company announces positive Phase 3 trial results or receives FDA approval, the market reaction is often immediate and substantial. This is not just speculation. These milestones ...

Needing a positive result to keep their Champions League campaign on track, Galatasaray are not the side Manchester City ...